logo

SYNH(Delisted)

Syneos HealthยทNASDAQ
--
--(--)

SYNH Profile

Syneos Health, Inc.

A company that provides Phase I to IV clinical development services for the biopharmaceutical and medical device industries

--
08/13/2010
11/07/2014
NASDAQ Stock Exchange
28,768
12-31
Common stock
1030 Sync Street, Morrisville, North Carolina , 27560-5468
--
Syneos Health, Inc., a Delaware corporation incorporated on August 13, 2010. The company is a leading global contract research organization based on revenue and focuses on Phase 1 to Phase 4 clinical development services for the biopharmaceutical and medical device industries. The company provides customers with highly differentiated therapeutic orientation and expertise, especially in intractable diseases such as the central nervous system and tumors. The Company has been providing clinical development services in complex environments and has provided a proprietary, actionable approach to clinical trials through its trusted process approach.